Literature DB >> 10935484

Noninvasive assessment of tumor cell proliferation in animal models.

M Edinger1, T J Sweeney, A A Tucker, A B Olomu, R S Negrin, C H Contag.   

Abstract

Revealing the mechanisms of neoplastic disease and enhancing our ability to intervene in these processes requires an increased understanding of cellular and molecular changes as they occur in intact living animal models. We have begun to address these needs by developing a method of labeling tumor cells through constitutive expression of an optical reporter gene, and noninvasively monitoring cellular proliferation in vivo using a sensitive photon detection system. A stable line of HeLa cells that expressed a modified firefly luciferase gene was generated, and proliferation of these cells in irradiated severe combined immunodeficiency (SCID) mice was monitored. Tumor cells were introduced into animals via subcutaneous, intraperitoneal and intravenous inoculation and whole body images, that revealed tumor location and growth kinetics, were obtained. The number of photons that were emitted from the labeled tumor cells and transmitted through murine tissues was sufficient to detect 1x10(3) cells in the peritoneal cavity, 1x10(4) cells at subcutaneous sites and 1x10(6) circulating cells immediately following injection. The kinetics of cell proliferation, as measured by photon emission, was exponential in the peritoneal cavity and at subcutaneous sites. Intravenous inoculation resulted in detectable colonies of tumor cells in animals receiving more than 1x10(6) cells. Our demonstrated ability to detect small numbers of tumor cells in living animals noninvasively suggests that therapies designed to treat minimal disease states, as occur early in the disease course and after elimination of the tumor mass, may be monitored using this approach. Moreover, it may be possible to monitor micrometastases and evaluate the molecular steps in the metastatic process. Spatiotemporal analyses of neoplasia will improve the predictability of animal models of human disease as study groups can be followed over time, and this method will accelerate development of novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10935484      PMCID: PMC1508101          DOI: 10.1038/sj.neo.7900048

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  30 in total

1.  Photonic detection of bacterial pathogens in living hosts.

Authors:  C H Contag; P R Contag; J I Mullins; S D Spilman; D K Stevenson; D A Benaron
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

Review 2.  Severe combined immunodeficient mouse models of human leukemia.

Authors:  F M Uckun
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

3.  Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.

Authors:  H Chen; M A Biel; M W Borges; A Thiagalingam; B D Nelkin; S B Baylin; D W Ball
Journal:  Cell Growth Differ       Date:  1997-06

Review 4.  Marker proteins for gene expression.

Authors:  K V Wood
Journal:  Curr Opin Biotechnol       Date:  1995-02       Impact factor: 9.740

Review 5.  Optical investigations of physiology: a study of intrinsic and extrinsic biomedical contrast.

Authors:  B Chance; Q Luo; S Nioka; D C Alsop; J A Detre
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-06-29       Impact factor: 6.237

Review 6.  Chemistries and colors of bioluminescent reactions: a review.

Authors:  J W Hastings
Journal:  Gene       Date:  1996       Impact factor: 3.688

7.  Homing of fluorescently labeled murine hematopoietic stem cells.

Authors:  P J Hendrikx; C M Martens; A Hagenbeek; J F Keij; J W Visser
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

8.  Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.

Authors:  F M Uckun; H Sather; G Reaman; J Shuster; V Land; M Trigg; R Gunther; L Chelstrom; A Bleyer; P Gaynon
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

9.  Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy.

Authors:  J G Tjuvajev; R Finn; K Watanabe; R Joshi; T Oku; J Kennedy; B Beattie; J Koutcher; S Larson; R G Blasberg
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

10.  Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.

Authors:  K Takakuwa; K Fujita; A Kikuchi; S Sugaya; T Yahata; H Aida; T Kurabayashi; I Hasegawa; K Tanaka
Journal:  Jpn J Cancer Res       Date:  1997-02
View more
  57 in total

1.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.

Authors:  Alexei A Bogdanov; Charles P Lin; Maria Simonova; Lars Matuszewski; Ralph Weissleder
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Noninvasive real-time imaging of apoptosis.

Authors:  Bharathi Laxman; Daniel E Hall; Mahaveer Swaroop Bhojani; Daniel A Hamstra; Thomas L Chenevert; Brian D Ross; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

Review 3.  Use of reporter genes for optical measurements of neoplastic disease in vivo.

Authors:  C H Contag; D Jenkins; P R Contag; R S Negrin
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

4.  The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.

Authors:  Viviane Palhares Muniz; J Matthew Barnes; Seema Paliwal; Xuefeng Zhang; Xiaoyun Tang; Songhai Chen; Kokou D Zamba; Joseph J Cullen; David K Meyerholz; Shari Meyers; J Nathan Davis; Steven R Grossman; Michael D Henry; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2011-06-02       Impact factor: 5.852

5.  Shifting foci of hematopoiesis during reconstitution from single stem cells.

Authors:  Yu-An Cao; Amy J Wagers; Andreas Beilhack; Joan Dusich; Michael H Bachmann; Robert S Negrin; Irving L Weissman; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

Review 6.  Animal models of bone metastasis.

Authors:  Thomas J Rosol; Sarah H Tannehill-Gregg; Stephanie Corn; Abraham Schneider; Laurie K McCauley
Journal:  Cancer Treat Res       Date:  2004

7.  Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

Authors:  Lena J Gamble; Hideyo Ugai; Minghui Wang; Anton V Borovjagin; Qiana L Matthews
Journal:  J Mol Biochem       Date:  2012-02-15

8.  Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

Authors:  Christoph H Schimmelpfennig; Stephan Schulz; Caroline Arber; Jeanette Baker; Ingo Tarner; Jacqueline McBride; Christopher H Contag; Robert S Negrin
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 9.  Bioluminescence imaging.

Authors:  Ruxana T Sadikot; Timothy S Blackwell
Journal:  Proc Am Thorac Soc       Date:  2005

10.  INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model.

Authors:  R Graeser; N Esser; H Unger; I Fichtner; A Zhu; C Unger; F Kratz
Journal:  Invest New Drugs       Date:  2009-01-08       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.